Quick answer. Obesity is a chronic medical condition driven by biology, hormones, environment and genetics, not simply a lack of willpower, and it raises the risk of type 2 diabetes, heart disease, stroke, obstructive sleep apnoea, fatty liver and some cancers. A doctor-supervised weight-management programme assesses your BMI, waist and metabolic health, treats underlying causes (such as thyroid problems or PCOS), and builds a stepped plan: lifestyle and dietitian support first, then weight-loss medications such as GLP-1 injections (Wegovy, Saxenda, Mounjaro, all prescription-only), and bariatric surgery for severe or high-risk cases. Singapore uses lower Asian BMI cut-offs (overweight from about 23, obese from about 27.5), so you should see a doctor if your BMI is in the obese range, you have weight-related health problems, or you are struggling despite real effort. Avoid quick-fix slimming pills and unregulated online products, which the Health Sciences Authority has repeatedly found adulterated with banned substances such as sibutramine.
Carrying excess weight is one of the most common health concerns in Singapore, but it is also one of the most misunderstood. Modern medicine treats obesity as a chronic, relapsing disease rather than a personal failing, and there is now a clear ladder of evidence-based, doctor-supervised options ranging from structured lifestyle and dietitian support to GLP-1 medications and surgery. This guide explains how Singapore measures weight risk using Asian BMI cut-offs, how a medical weight-management programme works, what the realistic options and costs are across public and private care, and the warning signs that mean it is time to seek professional help instead of an unregulated slimming product.
At a glance
| Approach | Best for / what it involves | Typical cost |
|---|---|---|
| Lifestyle and dietitian programme (public) | First-line for most; structured diet, activity and behaviour change; polyclinic and hospital dietitian-led programmes | Heavily subsidised for eligible Singaporeans (nominal consult fees) |
| Lifestyle and dietitian programme (private) | Faster access, personalised coaching and meal planning | Varies by clinic; typically several hundred dollars per programme/course |
| Saxenda (liraglutide), daily GLP-1 injection | BMI in obese range, or overweight with complications; prescription-only | ~SGD 400-700 per month at full maintenance dose |
| Wegovy (semaglutide), weekly GLP-1 injection | Obesity or overweight with weight-related conditions; prescription-only | ~SGD 350-1,000 per month depending on dose/provider |
| Mounjaro (tirzepatide), weekly GLP-1/GIP injection | Adults meeting BMI/comorbidity criteria; prescription-only (HSA-approved for weight management, 2025) | Varies by dose and provider; broadly comparable to other GLP-1s |
| Bariatric (metabolic) surgery | Severe obesity (BMI ~37.5+, or ~32.5+ with conditions); sleeve gastrectomy, gastric bypass, balloon | ~SGD 8,000-10,000 subsidised; ~SGD 25,000-28,000 unsubsidised/private |
Why obesity is a medical condition, not just willpower
Obesity is recognised internationally as a chronic medical condition influenced by genetics, hormones, sleep, medications, mental health, environment and the body’s own appetite-regulating biology. The body actively defends a higher weight, which is why many people regain weight after dieting, and why sustained loss usually needs medical support rather than effort alone.
It matters because excess weight is a major risk factor for serious illness. According to Singapore’s HealthHub, a BMI of 27.5 kg/m2 or higher raises the risk of type 2 diabetes, high blood pressure, heart disease, stroke, certain cancers, and bone and joint disorders. Obesity is also strongly linked to obstructive sleep apnoea and non-alcoholic fatty liver disease. The encouraging side is that even a 5-10% reduction in body weight can meaningfully improve blood sugar, blood pressure and cholesterol.
Understanding BMI and waist in the Singapore (Asian) context
Singapore uses lower BMI cut-offs than the global WHO standard because clinical evidence shows people of Asian descent develop diabetes and cardiovascular disease at lower body weights. The Health Promotion Board and Ministry of Health categories are:
- Healthy: BMI 18.5-22.9 kg/m2
- Overweight / moderate risk: BMI 23.0-27.4 kg/m2
- Obese / high risk: BMI 27.5 kg/m2 and above
BMI is a screening tool, not a complete picture. It can over- or under-estimate risk in very muscular people, older adults or during pregnancy, so doctors also consider waist circumference (a marker of harmful abdominal fat) alongside blood pressure, blood sugar, cholesterol and liver health to gauge your true metabolic risk.
How a doctor-supervised weight-management programme works
A medical programme begins with a thorough assessment rather than a diet sheet. Your doctor will measure BMI and waist, review your weight history, eating and activity patterns, sleep, mood and medications, and run blood tests to check for metabolic complications and reversible causes of weight gain such as an underactive thyroid, polycystic ovary syndrome (PCOS), or weight-promoting medications.
From there, the team builds an individualised, stepped plan and reviews progress over time. Hospital-based centres such as the SGH Obesity Centre (formerly the LIFE Centre) and NUH’s Centre for Obesity Management and Surgery use a multidisciplinary team of endocrinologists, dietitians, physiotherapists, psychologists and bariatric surgeons, so treatment can be escalated or combined as needed rather than relying on a single quick fix.
The ladder of treatment options
Medical weight management follows a stepped approach, with intensity matched to your BMI, health risks and response:
- Lifestyle and behavioural support (first-line for everyone): structured changes to diet, physical activity, sleep and habits, often with behavioural coaching. A dietitian-led programme can achieve around 5% weight loss through dietary change alone.
- Dietitian and allied-health input: personalised meal plans, exercise prescription and psychological support to make changes sustainable.
- Weight-loss medications (prescription-only): GLP-1 and dual GLP-1/GIP receptor agonists such as Saxenda (liraglutide), Wegovy (semaglutide) and Mounjaro (tirzepatide). These are typically considered when BMI is around 30 and above, or about 27.5-29.9 in people of Asian descent who already have obesity-related conditions. They must be prescribed and monitored by a doctor.
- Bariatric (metabolic) surgery for severe cases: options such as laparoscopic sleeve gastrectomy, Roux-en-Y gastric bypass and intragastric balloon. Under MOH guidance, surgery is generally offered at BMI above about 37.5, or above about 32.5 with obesity-related conditions such as type 2 diabetes or sleep apnoea.
When to see a doctor
It is worth seeking medical help if any of the following apply:
- Your BMI is in the obese range (27.5 kg/m2 or above by Asian cut-offs).
- You have weight-related health problems such as type 2 diabetes, high blood pressure, high cholesterol, fatty liver, joint pain or snoring and daytime sleepiness suggestive of sleep apnoea.
- You are gaining weight unexpectedly, or struggling to lose weight despite genuine, sustained effort, which may point to an underlying cause worth investigating.
You can start with a polyclinic or your family doctor, who can assess you and refer you to a hospital weight or obesity centre if more intensive or surgical care is appropriate. Seeking help early, before complications develop, gives the best results.
Public vs private care, and avoiding unsafe products
Public care through polyclinics and hospital obesity centres tends to be more affordable, with subsidies for eligible Singaporeans, and is well suited to people who need multidisciplinary or surgical input. Private clinics and telehealth providers offer faster access and convenience, particularly for medication-based programmes, but at higher out-of-pocket cost. Note that GLP-1 medications for weight loss are generally not covered by MediSave or MediShield Life.
Whichever route you choose, avoid unregulated “slimming” pills, teas and online products promising rapid results. The Health Sciences Authority (HSA) has repeatedly found such products, often marketed as “natural” or “herbal”, adulterated with banned substances such as sibutramine (prohibited in Singapore since 2010 over heart-attack and stroke risk). Reported harms include severe palpitations, hallucinations, hospitalisation and at least one case requiring resuscitation. Prescription weight-loss medication should only be obtained through a licensed doctor.
Related guides
- Best Bariatric & Weight-Loss Clinics in Singapore — our editorial shortlist
- bariatric & weight-loss clinics directory
- Weight-loss injections (GLP-1) guide
- Bariatric surgery cost & MediSave
- Ozempic vs Wegovy vs Mounjaro compared
Sources
- HealthHub (HPB/MOH) – Weight, BMI and Health Problems
- SGH Obesity Centre (formerly LIFE Centre) – services and surgical options
- NUH Centre for Obesity Management and Surgery (COMS)
- SingHealth – Bariatric and metabolic surgery
- HSA Alert – weight loss products found to contain banned substance sibutramine
- HPB-MOH Clinical Practice Guidelines: Obesity (BMI cut-offs and drug-therapy thresholds)
Related conditions & guides
Related conditions and guides you may find useful:
- Childhood Obesity in Singapore
- Fatty Liver Disease in Singapore
- Managing Type 2 Diabetes in Singapore
Part of our Weight & metabolic health guides · Browse all health topics